These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31018569)

  • 21. Tpl-2 kinase downregulates the activity of p53 and enhances signaling pathways leading to activation of activator protein 1 induced by EGF.
    Khanal P; Lee KY; Kang KW; Kang BS; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):682-9. PubMed ID: 19221002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
    Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
    Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation.
    Zhu F; Zykova TA; Peng C; Zhang J; Cho YY; Zheng D; Yao K; Ma WY; Lau AT; Bode AM; Dong Z
    Cancer Res; 2011 Jan; 71(2):393-403. PubMed ID: 21224359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axis.
    Zhang D; Liu J; Mi X; Liang Y; Li J; Huang C
    Cell Death Dis; 2014 Nov; 5(11):e1535. PubMed ID: 25412313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
    Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
    BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
    Stratford AL; Reipas K; Hu K; Fotovati A; Brough R; Frankum J; Takhar M; Watson P; Ashworth A; Lord CJ; Lasham A; Print CG; Dunn SE
    Stem Cells; 2012 Jul; 30(7):1338-48. PubMed ID: 22674792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RSK2 as a key regulator in human skin cancer.
    Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
    Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells.
    van Riggelen J; Buchwalter G; Soto U; De-Castro Arce J; zur Hausen H; Wasylyk B; Rösl F
    J Biol Chem; 2005 Feb; 280(5):3286-94. PubMed ID: 15548518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.
    Plaza-Menacho I; van der Sluis T; Hollema H; Gimm O; Buys CH; Magee AI; Isacke CM; Hofstra RM; Eggen BJ
    J Biol Chem; 2007 Mar; 282(9):6415-24. PubMed ID: 17209045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
    Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering.
    Aksan Kurnaz I
    Biotechnol Bioeng; 2004 Dec; 88(7):890-900. PubMed ID: 15515167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
    Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
    J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
    Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
    EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of histone H2B serine 32 is linked to cell transformation.
    Lau AT; Lee SY; Xu YM; Zheng D; Cho YY; Zhu F; Kim HG; Li SQ; Zhang Z; Bode AM; Dong Z
    J Biol Chem; 2011 Jul; 286(30):26628-37. PubMed ID: 21646345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isobavachalcone exerts anti‑proliferative and pro‑apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway.
    Li B; Xu N; Wan Z; Ma L; Li H; Cai W; Chen X; Huang Z; He Z
    Oncol Rep; 2019 Jun; 41(6):3355-3366. PubMed ID: 30942462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of ELK3 to regulate peritumoral lymphangiogenesis and VEGF-C production in triple negative breast cancer cells.
    Oh N; Park JI; Park JH; Kim KS; Lee DR; Park KS
    Biochem Biophys Res Commun; 2017 Mar; 484(4):896-902. PubMed ID: 28188790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
    Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
    Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy.
    Park JH; Kim KP; Ko JJ; Park KS
    Biochem Biophys Res Commun; 2016 Aug; 477(2):277-82. PubMed ID: 27301639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.